Second Alzheimer's Drug In The Pipeline Promises To Slow Worsening But With Safety Concern
WASHINGTON (AP) - Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening - by about four to seven months, researchers reported Monday. Eli Lilly and…
